Skip to main content
Clinical Trials/NCT01816867
NCT01816867CompletedNot Applicable

Laparoscopic and Open Ventral Hernia Repair Using the Intramesh T1: a Prospective, Multicenter Registry

be Medical1 site in 1 country96 target enrollmentStarted: January 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
96
Locations
1
Primary Endpoint
Recurrence rate at 12 months determined by clinical examination

Study Overview

Brief Summary

The purpose of the registry is to evaluate safety and efficacy of the Intramesh T1. This registry will collect data from 100 patients treated for a ventral hernia repair.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient is older than 18 years
  • Written informed consent is obtained from patient
  • Patient with a primary or incisional ventral hernia

Exclusion Criteria

  • Patient with a recurrent ventral hernia
  • Patient with ASA class 5 and 6
  • Patient underwent emergency surgery
  • Patient is pregnant
  • Patient with a known allergy to components of the ePTFE prosthesis
  • Patient has a life expectancy less than 1 year
  • Patient is unable to be compliant with the follow-up visits due to geographical, social or psychological factors

Outcomes

Primary Outcomes

Recurrence rate at 12 months determined by clinical examination

Time Frame: 12 months

Secondary Outcomes

  • Seroma(1 month)
  • Freedom from hernia-related reinterventions(12 months)
  • Late complications(12 months)
  • Intraoperative complications(peri-procedural)
  • Post-operative complications(up to 30 days)

Investigators

Sponsor
be Medical
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials